Reservoir Neuroscience is a biotech company advancing a novel therapy to reverse brain vascular pathology in aging and neurodegenerative diseases. In these critically unmet diseases, the brain's blood vessels become damaged and dysfunctional; causing inflammation that drives disease outcomes. This vascular pathology is the earliest biomarker of neurodegeneration and defines the largest patient segment yet has never been treated.Reservoir Neuroscience developed a proprietary human organ chip platform to discover novel, class-leading compounds that restore brain vascular health, offering a first-in-kind approach to reverse vascular pathology and neuroinflammation.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/18/24 | $4,000,000 | Venture |
Healthspan Ventures Kizoo Technology Capital  R42 Fund | undisclosed |
